Haematological malignancies include lymphomas such as Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), leukaemia and multiple myeloma (MM). They can affect any organ system and positron emission tomography/computed tomography (PET/CT) has been accepted as part of the routine management of most of them. In this chapter were only considered recent systematic reviews and meta-analyses concerning the use of PET or PET/CT with 18F-FDG in haematological malignancies dividing the results by the main areas of application.
Evidence-based PET for haematological tumours
Bertagna F.;Giubbini R.;Albano D.
2020-01-01
Abstract
Haematological malignancies include lymphomas such as Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), leukaemia and multiple myeloma (MM). They can affect any organ system and positron emission tomography/computed tomography (PET/CT) has been accepted as part of the routine management of most of them. In this chapter were only considered recent systematic reviews and meta-analyses concerning the use of PET or PET/CT with 18F-FDG in haematological malignancies dividing the results by the main areas of application.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
